These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8039478)

  • 21. Role of new and established antiepileptic drugs.
    Leppik IE
    Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Parvez NS; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiagabine in clinical practice.
    Genton P; Guerrini R; Perucca E
    Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiagabine.
    Shinnar S
    Semin Pediatr Neurol; 1997 Mar; 4(1):24-33. PubMed ID: 9097364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat.
    Dalby NO; Nielsen EB
    Neurosci Lett; 1997 Jun; 229(2):135-7. PubMed ID: 9223609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.
    White HS
    Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex.
    Leach JP; Sills GJ; Butler E; Forrest G; Thompson GG; Brodie MJ
    Gen Pharmacol; 1997 May; 28(5):715-9. PubMed ID: 9184808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
    McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
    Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
    Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
    J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology and clinical experience with tiagabine.
    Schachter SC
    Expert Opin Pharmacother; 2001 Jan; 2(1):179-87. PubMed ID: 11336578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism with GABAergic drugs in refractory epilepsy.
    Leach JP; Brodie MJ
    Lancet; 1994 Jun; 343(8913):1650. PubMed ID: 7911963
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of the safety of newer antiepileptic drugs.
    Shorvon S; Stefan H
    Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tiagabine: a GABA-ergic anti-epileptic drug].
    Herranz JL
    Rev Neurol; 1997 Oct; 25(146):1607-10. PubMed ID: 9462992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.
    Sackellares JC; Krauss G; Sommerville KW; Deaton R
    Epilepsia; 2002 Apr; 43(4):394-8. PubMed ID: 11952769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epilepsy in the elderly: the use of tiagabine.
    Pedersen B
    Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.